Gilder Gagnon Howe & Co’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1M | Buy |
465,401
+343,158
| +281% | +$14.8M | 0.21% | 87 |
|
|
2025
Q1 | $4.23M | Buy |
122,243
+73,013
| +148% | +$2.52M | 0.06% | 142 |
|
|
2024
Q4 | $1.35M | Sell |
49,230
-182
| -0.4% | -$4.99K | 0.01% | 198 |
|
|
2024
Q3 | $1.26M | Buy |
49,412
+5,110
| +12% | +$130K | 0.02% | 200 |
|
|
2024
Q2 | $1.12M | Sell |
44,302
-997
| -2% | -$25.3K | 0.01% | 200 |
|
|
2024
Q1 | $1.4M | Buy |
45,299
+5,177
| +13% | +$160K | 0.02% | 200 |
|
|
2023
Q4 | $1.62M | Sell |
40,122
-4
| -0% | -$161 | 0.02% | 190 |
|
|
2023
Q3 | $1.06M | Buy |
40,126
+4,570
| +13% | +$121K | 0.02% | 210 |
|
|
2023
Q2 | $612K | Buy |
35,556
+3,716
| +12% | +$63.9K | 0.01% | 242 |
|
|
2023
Q1 | $528K | Sell |
31,840
-699
| -2% | -$11.6K | 0.01% | 219 |
|
|
2022
Q4 | $248K | Sell |
32,539
-15,861
| -33% | -$121K | ﹤0.01% | 233 |
|
|
2022
Q3 | $481K | Sell |
48,400
-348
| -0.7% | -$3.46K | 0.01% | 221 |
|
|
2022
Q2 | $443K | Sell |
48,748
-796,327
| -94% | -$7.24M | 0.01% | 226 |
|
|
2022
Q1 | $8.58M | Sell |
845,075
-185
| -0% | -$1.88K | 0.08% | 148 |
|
|
2021
Q4 | $14.1M | Buy |
845,260
+89,938
| +12% | +$1.5M | 0.08% | 156 |
|
|
2021
Q3 | $35.4M | Sell |
755,322
-2,651
| -0.3% | -$124K | 0.18% | 121 |
|
|
2021
Q2 | $46.2M | Sell |
757,973
-6,794
| -0.9% | -$414K | 0.23% | 108 |
|
|
2021
Q1 | $47.1M | Buy |
+764,767
| New | +$47.1M | 0.25% | 103 |
|